bitBiome, Inc.

bitBiome, Inc. logo

As of March 2024

City	Year of Establishment	Founder
Shinjuku, Tokyo	2018	Masahito Hosokawa, Ph. D.

Partner VC	Latest round of Fundraising	Valuation
-	Series B2	Non-Disclosure

Contact Information : 03-6205-5662
info@bitbiome.bio
Website : bitBiome, Inc.

Program name

Deep-Tech Startups Support Program

Research theme

Technological Enhancements and Business Validation Toward International Development of Microbial Gene Database

Business Plan

bitBiome, Inc. contributes to solving R&D and production issues in the bio-manufacturing industry through the realization of the discovery and improvement of optimal genes by using our core technologies: the one and only single-cell genome analysis technology "bit-MAP®", a vast and highly accurate microbial genome database "bit-GEM", an enzyme discovery and modification platform with world-class accuracy and speed "bit-QED". This grant project aims to support entry into the primary market for biomanufacturing utilizing microbial gene resources in the United States. It involves the improvement of our microbial single-cell genome sequencing technologies that enable efficient analysis of overseas environmental samples.

Research Outline

In this R&D effort, we will improve our existing microbial genome analysis technology to enable efficient analysis of environmental samples, adapt it to the U.S. market, and also demonstrate its performance and feasibility for commercialization.

Phase	Business Area/Field	Research Period	Research Grant Amount
PCA	Food & Agricuture	2023～2027 FY	JPY 440 million

International collaborative technology demonstration

Countries/Regions	Collaborative activity outline
United States	- Local base establishment - Supply chain develop Through the international demonstration activities, we will investigate the feasibility of commercialization in the U.S. market, clarify the necessary technical specifications, and then improve the technology and implement it overseas. The following activities will be undertaken: 1) research on business feasibility and regulations, 2) development of lab or office in the U. S., and 3) demonstration of microbial genome analysis and genetic data collection performance of overseas environmental samples using the improved technology.

Countries/Regions

Collaborative activity outline

United States

- Local base establishment
- Supply chain develop

Through the international demonstration activities, we will investigate the feasibility of commercialization in the U.S. market, clarify the necessary technical specifications, and then improve the technology and implement it overseas. The following activities will be undertaken: 1) research on business feasibility and regulations, 2) development of lab or office in the U. S., and 3) demonstration of microbial genome analysis and genetic data collection performance of overseas environmental samples using the improved technology.

Download this page（191KB）